Esophageal cancer has a low survival rate, which is significantly improved through early detection, as well as monitoring of a common pre-cursor, Barrett’s esophagus. Optical Coherence Tomography is a low coherence interferometry technique which produces three-dimensional depth scans of tissues. OCT provides morphology but lacks in molecular specificity, and can thus be combined with targeted Near Infrared Fluorescence imaging. The viability of this dual-modality technique for use in detecting BE and esophageal cancer is assessed using topically and intravenously administered Bevacizumab in combination with an OCT-NIRF system, to produce ex vivo tissue scans, which are then histology matched.
|